Regular, long-term aspirin use reduces risk of colorectal cancer
January 22, 2008The use of regular, long-term aspirin and non-steroidal anti-inflammatory drugs (NSAIDs) reduces the risk associated with colorectal cancer, according to a study published in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. However, the use of aspirin for chemoprevention of colorectal cancer may require using the drug at doses that are higher than recommended over a long period of time, which may cause serious side effects including gastrointestinal bleeding.
“While the results of our study show that aspirin should not currently be recommended for the chemoprevention of colorectal cancer in a healthy population, there is a need for further studies to help identify for which patients the potential benefits outweigh the risks,” according to Andrew T. Chan, MD, MPH, Massachusetts General Hospital and lead author of the study. “We also need to improve our understanding of how aspirin works to prevent and inhibit the formation of colorectal cancer.”
Study participants were enrolled in the Health Professionals Follow-up Study, a large prospective cohort study which has provided detailed and updated information on aspirin use.
Researchers found that men who used aspirin regularly experienced a significantly lower risk of colorectal cancer, including distal colon cancer, proximal colon cancer and rectal cancer, even after controlling for other risk factors. The reduction in risk was seen in both early (stage I/II) and advanced (stage III/IV) colorectal cancers. There were 975 documented cases of colorectal cancer over 761,757 person-years, among the 47,636 eligible men. Participants who reported regular aspirin use, equal to or more than twice a week, were older, more likely to have smoked, used multivitamins and folate, and consumed slightly more alcohol.
In an average-risk population of men, results showed that the benefit of aspirin was not apparent until after more than five years of use. The greatest reduction in risk was observed at cumulative doses of more than 14 standard tablets (325 mg) per week, which is higher than normally recommended. The benefit of aspirin use appears to diminish less than four years after stopping use and is not evident after four to five years of discontinued use.
The Health Professionals Follow-up Study has been conducted on 51,529 U.S. male dentists, optometrists, osteopaths, podiatrists, pharmacists and veterinarians, who returned a mailed health questionnaire in 1986. The questionnaire included questions about diet, aspirin use and medical diagnoses, including cancer. The biennial questionnaires ask for updated information including cancer diagnoses and aspirin use. The participants were between 40 and 75 years of age when the study began.
This year an estimated 147,000 Americans will be diagnosed with colorectal cancer and 56,500 will die from this disease, with an approximate 1-in-18 lifetime probability of developing colorectal cancer.
Source: American Gastroenterological Association
-
Recommended services not always given during patients' annual exams
Jan 18, 2012 |
not rated yet |
0
-
Preventive care: It's free, except when it's not
Dec 28, 2011 |
5 / 5 (4) |
8
-
NSAID use associated with lower colorectal cancer mortality rates among postmenopausal women
Oct 24, 2011 |
not rated yet |
0
-
Aspirin's ability to protect against colorectal cancer may depend on inflammatory pathways
Mar 09, 2011 |
not rated yet |
0
-
Common bone drugs may reduce colon cancer risk
Feb 16, 2011 |
5 / 5 (2) |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (30) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (3) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (1) |
0
-
Is Everyday Technology Killing Us?
Feb 08, 2012
-
Exercise and weight loss
Feb 08, 2012
-
Why do we have head aches? Our brains can't feel anything.
Feb 07, 2012
-
"The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
Feb 04, 2012
-
Oncolytic adenovirus
Feb 04, 2012
-
Nutrition label stuffs and diets
Feb 02, 2012
- More from Physics Forums - Medical Sciences
More news stories
Researchers develop new method for creating tissue engineering scaffolds
Researchers at Northwestern University have developed a new method for creating scaffolds for tissue engineering applications, providing an alternative that is more flexible and less time-intensive than current technology.
1 hour ago |
5 / 5 (1) |
0
|
Molecular profiling reveals differences between primary and recurrent ovarian cancers
There is a need to analyze tumor specimens at the time of ovarian cancer recurrence, according to a new study published in Molecular Cancer Therapeutics. Researchers used a diagnostic technology called molecular profiling to examine ...
1 hour ago |
not rated yet |
0
|
Health experts, scientists to discuss bird flu studies
The World Health Organization said Friday it will meet next week to determine whether scientists can publish research on a bird flu virus that may be easily passed among humans.
44 minutes ago |
not rated yet |
0
C-sections linked to breathing problems in preterm infants
Research conducted at Yale School of Medicine shows that a cesarean (C-section) delivery, which was thought to be harmless, is associated with breathing problems in preterm babies who are small for gestational age.
1 hour ago |
not rated yet |
0
US issues guidelines to avoid heparin contamination
Four years after US drug-maker Baxter International's blood thinner heparin was contaminated in China, causing dozens of deaths, US regulators on Friday issued draft guidelines for safe production.
Medicine & Health / Medications
24 minutes ago |
not rated yet |
0
Hovering not hard if you're top-heavy, researchers find
Top-heavy structures are more likely to maintain their balance while hovering in the air than are those that bear a lower center of gravity, researchers at New York University's Courant Institute of Mathematical Sciences ...
Grass to gas: Researchers' genome map speeds biofuel development
Researchers at the University of Georgia have taken a major step in the ongoing effort to find sources of cleaner, renewable energy by mapping the genomes of two originator cells of Miscanthus x giganteus, a large perenn ...
Putting the squeeze on planets outside our solar system
(PhysOrg.com) -- Using high-powered lasers, scientists at Lawrence Livermore National Laboratory and collaborators discovered that molten magnesium silicate undergoes a phase change in the liquid state, abruptly ...
Review: Netflix and Hulu's new scripted originals
Within just over a week, Netflix and Hulu are both debuting their first stabs at original scripted programming.
India probes Google over 'forex transactions'
Indian authorities are probing whether online giant Google broke domestic foreign-exchange transactions rules while shifting funds abroad, the Press Trust of India reported on Friday.
Germany freezes signing of disputed Internet pact
Germany on Friday halted the signing of a controversial international accord billed as a way to beat online piracy that has sparked angry protests, saying it needed more time to consider it.